The day is fast approaching when doctors will be able to use genetic or molecular tests to personalize patients' pharmacological regimens. "Today, we are seeing the first applications (of genetic technology)," Robert Field, chairman of the health policy and public health department at the University of the Sciences in Philadelphia, told The Wall Street Journal (2/14/2007). "I think 5 years from now, certainly 10 years from now, this will indeed dominate medicine."
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not included in the final fee schedule for 2027, according to ACOG.